|
|
Pregnancy Rates
Statistics Explained
We are proud to be SART members and, as such, are required to report
our statistics to the CDC National Registry. We do so, and are quite proud
of our statistics, but feel that patients and potential patients need to
understand the complexities involved. Program statistics should be but a
small part of the decision making process involved in selecting a program.

"There are three kinds of lies: lies, damned lies and statistics."
-- Autobiography of Mark Twain
- All statistical methods assess data from populations.
- But a patient is not a population.
- Each patient has a unique set of circumstances that defines their
own specific likelihood of achieving a pregnancy.
- IVF statistics will look good if population data is controlled.
In the words of a famous European infertility expert:
“The patients who are easiest to get pregnant get pregnant
most easily.”
Let’s look at two different types of Physicians Practice Statistics --
Dr. Lookgood and Dr. Helpall:
| |
Dr. Lookgood |
Dr. Helpall |
| Screen (phone, records) |
100 |
100 |
| Patients seen |
80 (80%) |
96 (96%) |
| Accepted to program |
60 (75%) |
94 (98%) |
| Cycles promptly started |
50 (83%) |
94 (100%) |
| Cycles not canceled |
35 (70%) |
90 (96%) |
| Transfers |
33 (94%) |
80 (89%) |
| Transfers, 4 or more embryos |
31 (94%) |
10 (13%) |
| Pregnancies |
14 |
17 |
| Pregnancies, ongoing/births |
11 (79%) |
12 (71%) |
Dr. Helpall treats patients according to a philosophy typical of
medicine in most fields, and the philosophy that we believe is the correct
one:
Take patients in the order that they come to you, help those who
have a chance of being helped, do your best for each individual patient,
and let population statistics fall where they may.
As you can see, Dr. Lookgood has a different vision. Take a second look
at the same data as reported following the guidelines of the National
Registry.
“Pregnancy rate” statistics look like this:
| |
Dr. Lookgood |
Dr. Helpall |
| Pregnancies per transfer |
42% |
21% |
| Pregnancies per retrieval |
40% |
19% |
| Pregnancies per cycle |
28% |
18% |
| Ongoing/births per transfer |
33% |
15% |
| Ongoing/births per retrieval |
31% |
13% |
| Ongoing/births per cycle |
22% |
13% |
The misguided focus on “success rates” has created strong incentives,
economic and otherwise, for IVF programs –particularly those that
advertise nationally—to “game” the system.
Statistical results summaries, such as the National Registry actually
make the problem worse, because despite the best of intentions the data
receive an imprint of authenticity, objectivity, and fairness that they
even theoretically cannot have.
At Overlake Reproductive Health we are quite proud of our statistics.
We strive to treat those patients whom we can help. We don’t try to
pre-select our patient population in order to benefit our statistics.
Here are a few of the methods used by some other infertility treatment
centers for achieving "good looking" statistics. And we again remind our
readers that the primary theme behind making infertility therapy
statistics look good is not to corrupt the mathematical computation but
to select the patients and cycles, and hence the data, going into those
calculations.
- Attract better patients with a "refund package" or “shared risk”:
What ever the name it is disguised under, Refund or "Pregnancy
Guarantee™" packages offer enhanced up-front fees for IVF to selected
qualifying patients who receive a rebate if a pregnancy is not attained.
Qualifying patients necessarily includes only more favorable patients,
and excludes those representing more difficult medical challenges. From
a statistics perspective this type of program ensures enrichment in
favorable patients and leads almost automatically to "better" success
rates. IVF centers which have a substantial fraction of their patients
involved in refund programs are virtually guaranteed to manifest higher
average "success rates" than those with fewer such patients or which do
not offer refund programs at all. This apparent improvement in "success
rates" when refund programs are prominent is, of course, attained
without producing a true improvement in the quality of care provided to
anyone.
- Classify difficult patients as research subjects: Certain IVF
centers enhance their statistics dramatically by the simple expedient of
classifying their most difficult patients as "research patients", and
then failing to include them as part of their "real" clinical
statistics. This allows such facilities, of course, to maintain their
volume of activity, and do the same type of research that is
appropriately done at many IVF facilities, while looking better than
their peers. Within any group, or age group cluster, of patients there
are very wide variations in the likelihood of pregnancy for individuals.
The systematic exclusion of the most challenging patients from the
clinical statistics enriches the success rate of the reported subset
automatically.
- Move challenging patients to donor egg services early: There
can be no question that donor egg substitution in circumstances where
the woman's ovaries show some aging effects or where egg quality appears
to be somewhat reduced can be very effective in achieving pregnancy. But
at what point should individual patients should be encouraged to
consider this alternative? Any IVF center that directs candidate
patients at a relatively early stage toward the donor egg process,
especially if this is reinforced by refusing to further provide
conventional IVF services to such women, will be assured of achieving
"better" statistics.
- Discourage embryo cryopreservation: This is powerful, yet
subtle. A patient goes through an IVF cycle, produces let us say 6 to 9
embryos, and is advised that her "embryos do not look good enough to
freeze". This forecloses the conventional decision to transfer
approximately 3 embryos, and cryopreserve the remainder to be used in
one or more frozen embryo transfer cycles if the initial embryo transfer
is unsuccessful.
Consider what happens when freezing is precluded. First, there will
usually be a larger number of embryos transferred than would otherwise
have been preferred by the couple - and the "success rate" statistics of
the IVF facility will thereby be enhanced. But the statistics will be
further improved for an additional, more complex reason. Patients vary
in the ease with which embryos will implant in their uterus and produce
a pregnancy. A patient may be perfectly normal from this perspective,
yet fail to become pregnant with her first fresh embryo transfer. There
is a substantial probability that such a "good" patient will then
conceive on her subsequent frozen transfer cycle(s). If she does so, she
is a statistical failure for "success rate" purposes, since this is
calculated from non-cryopreserved cycles, and she will not medically
reappear for a second fresh IVF cycle. But if freezing is not done, and
if a pregnancy does not result from the first fresh embryo transfer,
such patients will likely do second full IVF cycles. And many of them
will then become pregnant on this second fresh cycle.
Thus, the discouragement of freezing leads to a group of patients
doing repeat fresh IVF cycles which is predictably enriched for better
patients compared to what would happen if embryo freezing had been more
broadly utilized. The result is, automatically, "better" statistics in
the aggregated fresh cycles. And it need not perhaps be added that such
an approach enhances the economic benefit to the IVF center by
substituting a full IVF cycle for a much less costly frozen transfer
cycle.
In conclusion, we would like to express our respect for the
integrity of those many physicians in the IVF field who have resisted the
extremely strong pressures to modify their programs and policies to
optimize apparent "success rates". Predictably, but unfortunately, these
pressures have influenced the actions of some other IVF centers very
heavily. Simple formulas, and the reliance on statistics, cannot achieve
the desired goals. A system unsound in principle cannot, and should not,
be relied upon in practice.
|
2007 Clinical Pregnancy Rate/Transfer |
| |
Recipients Using Donor Eggs |
Using Patient's Own Eggs |
| < 35 yo |
35-37 yo |
38-40 yo |
41-42 yo |
> 42 yo |
Thawed Embryos |
| Clinical Pregnancy Rate/Transfer |
80%
**8/1075%
*9/12 |
67%
33/49 |
55%
6/11 |
58%
11/19 |
14%
1/7 |
33%
1/3 |
39%
9/23 |
| Average # Embryos Transferred |
2.1 |
2.2 |
2.3 |
2.4 |
2.7 |
3.7 |
2.0 |
|
2006 Clinical Pregnancy Rate/Transfer |
| |
Recipients Using Donor Eggs |
Using Patient's Own Eggs |
| < 35 yo |
35-37 yo |
38-40 yo |
41-42 yo |
> 42 yo |
Thawed Embryos |
| Clinical Pregnancy Rate/Transfer |
91%
**10/1177%
*10/13 |
60%
25/42 |
59%
10/17 |
21%
3/14 |
10%
1/10 |
50%
1/2 |
39%
9/23 |
| Average # Embryos Transferred |
2.1 |
2.3 |
2.5 |
2.1 |
3.1 |
2.5 |
2.0 |
We are proud of our donor egg program and our rates are world-class. We
have a cumulative 6 year (through 2007) donor egg pregnancy rate of:
75% Clinical Pregnancy Rate/Transfer (1)
While we are understandably proud of our ART success rates, with upward
trends attributable to an unremitting introduction of cutting edge
ideas and technology, it should be noted that a comparison of clinic
success rates may not be meaningful because patient medical
characteristics and treatment approaches may vary from clinic to clinic.
* All types of oocyte donors
** Anonymous oocyte donors only
(1) n=46/61 for anonymous donors. 71% clinical pregnancy rate/transfer,
n=52/73 for all donor cycles.
|
|